(株)メドレックスの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4586/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2014/02/14 | 日証協 | 707,601株 | +4.14% | 23,900株 | -91.48% | 349,818株 | +6.91% | 30,101株 | -19.11% |
2014/02/07 | 日証協 | 679,501株 | +33.89% | 280,600株 | +460.08% | 327,218株 | -21.94% | 37,210株 | -33.74% |
2014/01/31 | 日証協 | 507,501株 | +3.95% | 50,100株 | -42.48% | 419,208株 | +5.98% | 56,160株 | +114.35% |
2014/01/24 | 日証協 | 488,201株 | +2.52% | 87,100株 | +400.57% | 395,558株 | +11.69% | 26,200株 | -39.21% |
2014/01/17 | 日証協 | 476,201株 | +2.92% | 17,400株 | +53.98% | 354,158株 | +2.1% | 43,100株 | +91.56% |
2014/01/10 | 日証協 | 462,701株 | +1.67% | 11,300株 | +1312.5% | 346,858株 | +16.82% | 22,500株 | +20.32% |
2013/12/30 | 日証協 | 455,101株 | -0.35% | 800株 | -98.26% | 296,905株 | -4.27% | 18,700株 | -35.86% |
2013/12/27 | 日証協 | 456,701株 | +2.74% | 45,900株 | -86.42% | 310,157株 | -31.15% | 29,153株 | -84.99% |
2013/12/20 | 日証協 | 444,501株 | +113.5% | 338,087株 | +459.83% | 450,458株 | +72.55% | 194,288株 | +866.61% |
2013/12/13 | 日証協 | 208,200株 | -1.56% | 60,391株 | -39.6% | 261,056株 | -17.14% | 20,100株 | -46.4% |
2013/12/06 | 日証協 | 211,500株 | -0.94% | 99,991株 | +212.47% | 315,056株 | +2.26% | 37,500株 | +284.62% |
2013/11/29 | 日証協 | 213,500株 | +42.24% | 32,000株 | +150% | 308,106株 | +10.07% | 9,750株 | -63.78% |
2013/11/22 | 日証協 | 150,100株 | -5.3% | 12,800株 | -49.8% | 279,906株 | +9.47% | 26,917株 | -23.09% |
2013/11/15 | 日証協 | 158,500株 | +13.3% | 25,500株 | +177.17% | 255,689株 | +8.53% | 35,000株 | +37.75% |
2013/11/08 | 日証協 | 139,900株 | +3.4% | 9,200株 | -44.91% | 235,589株 | +13.77% | 25,408株 | -31.7% |
2013/11/01 | 日証協 | 135,300株 | -14.04% | 16,700株 | +209.26% | 207,081株 | +4.18% | 37,200株 | +143.14% |
2013/10/25 | 日証協 | 157,400株 | -0.94% | 5,400株 | +50% | 198,781株 | +12.7% | 15,300株 | -43.12% |
2013/10/18 | 日証協 | 158,900株 | +0.06% | 3,600株 | -62.11% | 176,381株 | +6.52% | 26,900株 | +268.09% |
2013/10/11 | 日証協 | 158,800株 | +2.98% | 9,500株 | -77.05% | 165,581株 | +3.38% | 7,308株 | -80.72% |
※株式分割は考慮していませんのでご注意ください。
Page Top